Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: Results of an open-label study

Epilepsy and Behavior

Volumn 5, Issue 4, 2004, Pages 509-512

  Morris, George L ^a   Hammer, Anne E ^b   Kustra, Robert P ^b   Messenheimer, John A ^b  

^a ST LUKE S MEDICAL CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Juvenile myoclonic epilepsy; Lamotrigine; Myoclonus; Valproate

Indexed keywords

LAMOTRIGINE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DIARRHEA; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ERUPTION; DRUG INDICATION; DRUG RESEARCH; DRUG WITHDRAWAL; EPIGASTRIC PAIN; EPILEPTIC AURA; EXPERIENCE; FEMALE; HAND DISEASE; HEADACHE; HEALTH STATUS; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MONOTHERAPY; MOTOR COORDINATION; MOTOR DYSFUNCTION; MYOCLONUS EPILEPSY; OPEN STUDY; RATING SCALE; SCHOOL CHILD; TIME; TREATMENT FAILURE; TREATMENT OUTCOME; TREMOR; VISUAL IMPAIRMENT; VOMITING;

ADOLESCENT; ANTICONVULSANTS; CHILD; DRUG EVALUATION; HUMANS; MYOCLONIC EPILEPSY, JUVENILE; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 4043123437     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.04.002     Document Type: Article

References (15)

1. Grünewald R.A. Panayiotopoulos C.P. Juvenile myoclonic epilepsy: a review Arch. Neurol. 50 1993 594-598
2. Panayiotopoulos C.P. Obeid T. Tahan A.R. Juvenile myoclonic epilepsy: a 5-year prospective study Epilepsia 35 1994 285-296
3. Pedersen S.B. Petersen K.A. Juvenile myoclonic epilepsy: clinical and EEG features Acta. Neurol. Scand. 97 1998 160-163
4. Karceski S. Morrell M. Carpenter D. The expert consensus guideline series: treatment of epilepsy Epilepsy Behav. 2 2001 A1-A50
5. Matsuo F. Lamotrigine Epilepsia 40 Suppl 5 1999 S30-S36
6. Buchanan N. The use of lamotrigine in juvenile myoclonic epilepsy Seizure 5 1996 149-151
7. Sharpe C. Buchanan N. Juvenile myoclonic epilepsy: diagnosis, management and outcome Med. J. Aust. 162 1995 133-134
8. Gericke C.A. Picard F. de Saint-Martin A. et al. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study Epileptic Disord. 1 1999 159-165
9. Timmings P.L. Richens A. Efficacy of lamotrigine as monotherapy in juvenile myoclonic epilepsy: pilot study results Epilepsia 34 Suppl 2 1993 160
10. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1989;30:389-99
11. Prasad A. Kuzniecky R.I. Knowlton R.C. et al. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy Arch. Neurol. 60 2003 1100-1105
12. Chadwick D. Monotherapy clinical trials of new antiepileptic drugs: design, indications, and controversies Epilepsia 38 Suppl 9 1997 S16-S20
13. Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy) Acta Neurol. Scand. 72 1985 449-459
14. Messenheimer J. Efficacy and safety of lamotrigine in pediatric patients J. Child Neurol. 17 Suppl 2 2002 2S34-2S42
15. Messenheimer J. Mullens E.L. Giorgi L. et al. Safety review of adult clinical trial experience with lamotrigine Drug Saf. 18 1998 281-296